Adlai Nortye Group Ltd.

ANL chart

Adlai Nortye Group Ltd. news

• Form 144 Adlai Nortye Group Ltd. For: 9 November By Investing.com

  Investing.com Canada · Nov 9, 4:05 AM EST

• Wall Street Analysts Are Bullish on Top Healthcare Picks

  The Globe and Mail · Nov 7, 2:05 AM EST

• ANL news: latest Azgard Nine Ltd updates

  Investify · Nov 6, 9:08 AM EST

• ANL Company Announcements - Azgard Nine Ltd

  Investify · Nov 5, 3:03 PM EST

• Analysts’ Top Healthcare Picks: Crispr Therapeutics AG (CRSP), Faeth Therapeutics (FTH)

  The Globe and Mail · Nov 4, 5:33 PM EST

• Stock rankings: top gainers, losers, market cap, dividends

  Quantisnow · Nov 3, 3:22 AM EST

• Adlai Nortye Announces Oral Presentation for AN4035 Program Update at the Upcoming 38th EORTC-NCI-AACR Symposium

  Yahoo Finance · Oct 27, 4:05 PM EDT

• Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab

  Yahoo Finance · Oct 15, 7:00 AM EDT

• Is Adlai Nortye Ltd. Sponsored ADR (ANL) Stock Outpacing Its Medical Peers This Year?

  Yahoo Finance · Oct 14, 8:40 AM EDT

• Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations

  Yahoo Finance · Sep 30, 7:00 AM EDT

• 4.8x P B? Adlai Nortye Group (ANL) On Its AN4035 Trial Progress

  Yahoo Finance · Sep 15, 1:12 PM EDT

• Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC

  Yahoo Finance · Sep 8, 7:00 AM EDT

Adlai Nortye Group Ltd. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-28
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-15
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-30
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-30
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-08
• 6-KCURRENT REPORT2026-08-26
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-19
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-14
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-03
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-07-17
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-04-16
• 20-FANNUAL REPORT2026-04-10

About Adlai Nortye Group Ltd.

Ticker

ANL (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Singapore

Incorporated in

Singapore

Fiscal year end

December 31

SEC CIK

1944552

Former names

Adlai Nortye Ltd.

Frequently asked questions